Depo-Provera Brain Tumor Screening: 7 Critical Steps Every Former User Should Know

These lawsuits follow major medical research showing that long-term use of the contraceptive injection Depo-Provera is linked to a significantly increased risk of developing meningiomas (brain tumors). Plaintiffs allege Pfizer failed to warn the public about this risk.

A meningioma is a tumor that forms on the membranes (meninges) that cover the brain and spinal cord. While often slow-growing, they can cause serious neurological damage and life-threatening complications as they grow and press on brain tissue.

According to a 2024 study published in the British Medical Journal, using Depo-Provera for more than one year increases the risk of developing a meningioma by 5.5 times (or 555%) compared to those who have not used the drug.

As of April 2026, the litigation is in its initial coordinated phase. Federal and state courts are managing discovery—the process of obtaining Pfizer’s internal documents—to determine exactly when the company knew about the tumor risks.

Eligibility generally requires proof of multiple Depo-Provera injections (usually for at least 1-2 years) followed by a medical diagnosis of an intracranial meningioma or a tumor requiring surgical removal.

Yes. Most meningiomas are technically non-cancerous, but the lawsuit focuses on the harm caused by the tumor’s growth, including the need for invasive brain surgery, permanent cognitive damage, and long-term medical monitoring.

Yes. Scientific evidence shows a clear dose-response link, meaning the risk increases the longer a woman is on the medication. Most law firms are prioritizing cases involving users who received shots for 12 months or more.

Symptoms include chronic headaches, vision changes (blurring/double vision), hearing loss, seizures, limb weakness, and loss of balance or coordination.

It is being handled as a Mass Tort. This ensures that every woman’s specific injury—whether it involved a single surgery or multiple procedures—is evaluated individually to maximize her personal settlement award.

Historically, Depo-Provera labels did not mention meningioma in the U.S. Litigation argues that Pfizer updated labels in other countries (like the UK) as far back as early 2024 but failed to provide the same warnings to American users in a timely manner.

It is the active progestin hormone in Depo-Provera. Scientific research suggests that certain brain tumors have progesterone receptors, meaning the synthetic hormones in the drug can act as “fuel” for tumor growth.

Claimants can seek compensation for medical bills (surgery, ICU stays, therapy), lost wages, diminished earning capacity, physical pain and suffering, and permanent neurological impairments.

Yes. Medical records, pharmacy records, or insurance logs showing your history of Depo-Provera injections are essential for building a successful claim.

Cases involving generic versions are evaluated individually. However, if you used the brand-name Pfizer product for any significant period, you likely have a stronger case against the original manufacturer.

While not strictly required, cases involving surgical intervention (craniotomy) or permanent vision/hearing loss are currently being prioritized due to the high severity of the damages.

Deadlines vary by state, but the clock usually starts from the date of your meningioma diagnosis or the date you learned of the link to Depo-Provera. Because many states have a 2-year limit, acting quickly is essential.

Most Depo-Provera lawyers work on a contingency fee basis. You pay nothing out of pocket, and the attorney only receives a percentage of your final settlement or award.

Yes. Both the original Depo-Provera (intramuscular) and the SubQ 104 (subcutaneous) versions contain the same active hormone linked to tumor growth.

Yes. If a family member passed away due to complications from a brain tumor or brain surgery after using the Depo shot, surviving family members can file a wrongful death claim.

A bellwether trial is a test case. The results help attorneys estimate the value of other similar claims and often pressure manufacturers to reach a global settlement for all victims.

While current litigation focuses heavily on meningiomas, legal teams are also investigating potential links to other hormone-sensitive tumors. However, the meningioma link is currently supported by the strongest scientific data.

Many states follow the “discovery rule,” meaning you may still be able to file if you only recently learned that your past brain tumor was potentially caused by the Depo-Provera shot.

These cases are complex and can take 2 to 4 years. With litigation actively moving in 2026, we are entering the most critical discovery and settlement evaluation phases.

While court filings are public records, your private medical history is strictly protected and is only shared with the court and necessary legal teams.

Generally, no. The scientific evidence currently shows that the risk becomes significant after long-term exposure (at least four injections or one year of use).

Yes. Women who used Hormone Replacement Therapy (HRT) containing the same medroxyprogesterone acetate and developed tumors may also have grounds for a claim.

A Master Complaint is a document that lists all common allegations against Pfizer. It allows thousands of individual women to join the litigation efficiently by filing a simplified “Short Form.”

You can receive a 100% free review of your brand usage and tumor diagnosis. Visit MassTortTraffic.com or call (+1) 210-940-9440 to speak with an advocate today.